ESTA Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$95.33median target· current $92.54 (+3.0%)9 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-1.470.0% YoY
Profit margin-19.1%HEALTHCARE
Market cap$2.72BMid cap
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 184.23
- P/S (TTM)
- 11.86
- EV/EBITDA
- -26.29
Profitability & growth
- ROE (TTM)
- -164.0%
- Operating margin
- -10.9%
- Revenue growth YoY
- 44.7%
- Dividend yield
- —
- Beta
- 1.07
Last earnings
May 6, 2026 · Estimate $-0.38 · Reported $-0.40
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Establishment Labs Holdings Inc
Company profileEstablishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for cosmetic and reconstructive plastic surgery. The company is headquartered in Alajuela, Costa Rica.
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 11401 CENTURY OAKS TERRACE, AUSTIN, TX
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$2.72B
Shares outstanding$29.4M
52W high$96.99
52W low$33.35
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent